•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A05914 Summary:

BILL NOA05914A
 
SAME ASSAME AS S05439-A
 
SPONSORWoerner
 
COSPNSR
 
MLTSPNSR
 
Amd §3306, Pub Health L
 
Designates Xylazine as a schedule III depressant.
Go to top

A05914 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         5914--A
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                     March 24, 2023
                                       ___________
 
        Introduced  by M. of A. WOERNER -- read once and referred to the Commit-
          tee on Health -- committee discharged, bill amended, ordered reprinted
          as amended and recommitted to said committee
 
        AN ACT to amend the public health law, in relation to designating  Xyla-
          zine as a schedule III depressant

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Subdivision (c) of schedule III  of  section  3306  of  the
     2  public  health  law  is  amended by adding a new paragraph 15 to read as
     3  follows:
     4    (15)  Xylazine  (N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3  thiazin-2-
     5  amine),  including  its salts, isomers and salts of isomers whenever the
     6  existence of such salts, isomers and salts of isomers is possible within
     7  the specific chemical designation.
     8    § 2. This act shall take effect on the ninetieth day  after  it  shall
     9  have become a law.
 
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD06914-02-3
Go to top